Reach 300+ senior oncology and biomarker decision-makers. Position your brand at the centre of the fastest-moving field in precision medicine.
Sponsor Boston 2027
Our sponsorship team replies within one working day.
Trusted by sponsors from our London 2026 launch edition
WHY SPONSOR
Sponsoring ImmunoMark Summit USA 2027 places your brand at the centre of the immuno-oncology and biomarker transformation happening right now in Boston and across the US market. You will gain direct access to 300+ high-level decision-makers (including CEOs, CSOs, VPs of R&D, Heads of Translational Medicine, and Clinical Biomarker Leads) in an environment specifically engineered for deep engagement, strategic dialogue, and long-term partnership building.
Unlike generic life sciences conferences, ImmunoMark Summit is a curated, senior-audience platform where your technology or service is showcased within a scientifically rigorous, commercially focused discourse.
Platinum & Gold tiers include a reserved branded speaking slot within the scientific programme
Dedicated 10×6 ft stand with table, chairs, and power outlet for demos and engagement
Post-event access to full delegate contact list for follow-up outreach and lead development
Pre-arranged private meetings with your highest-value prospects (Headline & Platinum)
Logo across website, agenda, email campaigns, on-site signage, and conference brochure
Pre- and post-event social media coverage across ImmunoMark LinkedIn and digital channels
The audience is curated for senior decision-makers and partnership-focused professionals, not junior networking traffic. CDx and IO partnerships rarely get signed at the booth, but they very often start there.
Marketing, BD and finance teams often judge events differently. Cost per qualified conversation is the measure that bridges them. These are the numbers worth tracking from Boston:
| What to measure | Why it matters |
|---|---|
| Pre-scheduled 1:1 meetings | Counts qualified conversations instead of badge scans |
| Share of meetings at VP level or above | Confirms decision-makers were actually in the room |
| Follow-ups that reach a second call | The clearest early sign of pipeline |
| Speaking session attendance | Measures thought-leadership reach |
| Time to first follow-up | A strong predictor of whether a deal progresses |
Boston’s biopharma community is dense and relationship-driven. Conversations that start at the summit often move into formal BD discussions within weeks, across Kendall Square and the Seaport.
Everything you need to build the internal business case:
TRUSTED BY
PACKAGES
Choose the package that best fits your goals, or build your own. All packages include prominent brand recognition across event marketing materials.
Pricing and available slots confirmed via direct discussion. Contact us to explore options.
Enquire →Not sure which package fits? Build your own. Mix and match speaking slots, exhibition space, delegate passes, branding options, and 1:1 meetings to create a bespoke package aligned to your exact objectives and budget.
Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.
1. Choose a package
2. Your numbers
Year-one value of a new pharma or biotech customer
Booth visits, networking and questions after your talk
Share of conversations worth a proposal
Your typical close rate
Sponsorship plus travel and team costs
expected first-year revenue for every $1 of your event budget
Estimates only, based on the numbers you enter. Meetings and inclusions from the Boston 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.
What sponsors said
Here is what sponsors told us at our London 2026 launch edition.
We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.
We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.
Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.
My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.
We got the occasion to discuss customer projects and understand their needs better and how we can help them.
The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.
Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.
The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.
Eight packages, from an exclusive Headline sponsorship for one company through Platinum, Gold and Silver tiers to exhibition and speaking options. You can also build your own package.
300+ senior decision-makers in immuno-oncology and biomarkers, including CEOs, CSOs, VPs of R&D, Heads of Translational Medicine and Clinical Biomarker Leads.
June 2027 in Boston, USA. Exact dates and venue details will be confirmed shortly.
Headline and Platinum include pre-arranged 1:1 meetings with your highest-value prospects. Platinum and Gold include a reserved speaking slot in the scientific programme.
Post-event access to the full delegate contact list for follow-up, plus pre- and post-event social media coverage across ImmunoMark's LinkedIn and digital channels.
ENQUIRE
Fill in the form below and our team will be in touch within 1 business day with full details and pricing.
Or email us directly: anandhu@convolign.com · +1-617-604-3359
300+ senior leaders. Two streams. One agenda: advancing precision oncology.
Waitlist for Boston Edition Register for San Diego Edition Register for London Edition